SCYNEXIS
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SCYNEXIS and other ETFs, options, and stocks.About SCYX
SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J.
CEODavid Angulo Gonzalez
CEODavid Angulo Gonzalez
Employees29
Employees29
HeadquartersJersey City, New Jersey
HeadquartersJersey City, New Jersey
Founded1999
Founded1999
Employees29
Employees29
SCYX Key Statistics
Market cap58.14M
Market cap58.14M
Price-Earnings ratio1.11
Price-Earnings ratio1.11
Dividend yield—
Dividend yield—
Average volume116.51K
Average volume116.51K
High today$1.58
High today$1.58
Low today$1.45
Low today$1.45
Open price$1.45
Open price$1.45
Volume157.70K
Volume157.70K
52 Week high$3.87
52 Week high$3.87
52 Week low$1.35
52 Week low$1.35